Seeking Alpha

Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long ...

SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today ...
Seeking Alpha

Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript

Welcome to the Rani Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are a in a listen-only mode. Following ...
Nasdaq

Rani Therapeutics Enters Research Agreement with Chugai Pharmaceutical to Explore Oral Delivery Technology for Antibody Development

Rani Therapeutics Holdings, Inc. has announced a research agreement with Chugai Pharmaceutical Co., Ltd. to evaluate the potential of Rani’s oral delivery technology, specifically the RaniPill®, for ...
abc27

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology ...

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $100 million in sales milestones and single digit ...
Insider Monkey

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript

Talat Imran: Thank you. I’m delighted to share the highlights of Rani Therapeutics’ strong performance in 2023 during which the company achieved numerous milestones in the development of its pipeline ...